Yu Joshua Cao
Affiliations: | 2013-2016 | Chemistry | Scripps Research Institute, La Jolla, La Jolla, CA, United States |
| 2017- | Chemical Biology and Biotechnology | Peking University Shenzhen Graduate School |
Google:
"Yu Cao"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Gang Bai | grad student | 2001-2007 | Nankai University |
| Michael G. Rosenblum | grad student | 2007-2013 | University of Texas, MD Anderson Cancer Center |
| Peter G. Schultz | post-doc | 2013-2016 | Scripps Institute |
Children
Sign in to add trainee| Zhidong Wang | grad student | 2018-2022 | Peking University |
| Lijun Zhao | grad student | 2018-2022 | Peking University |
| Shuhong Li | grad student | 2019-2023 | Peking University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Qiu Y, Qi Z, Wang Z, et al. (2022) EGF‑IL2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models. Oncology Reports. 49 |
| Liu D, Qi X, Wei X, et al. (2022) A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy. Theranostics. 12: 7788-7803 |
| Zhao L, Li S, Wei X, et al. (2022) A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL. Blood |
| Xia Y, Li X, Yang L, et al. (2021) Development of thermostable sucrose phosphorylase by semi-rational design for efficient biosynthesis of alpha-D-glucosylglycerol. Applied Microbiology and Biotechnology |
| Cao YJ, Yu C, Wu KL, et al. (2021) Synthesis of precision antibody conjugates using proximity-induced chemistry. Theranostics. 11: 9107-9117 |
| Bloom JA, Sekigami Y, Young R, et al. (2021) Discordance in Oncotype DX Breast Recurrence Score Results for Bilateral Breast Cancer. Annals of Surgical Oncology |
| Cao YJ, Wang X, Wang Z, et al. (2021) Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers. Acs Synthetic Biology |
| Li C, Cao Y, Zhang L, et al. (2021) CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth and . Frontiers in Molecular Biosciences. 8: 638995 |
| Sekigami Y, Char S, Mullen C, et al. (2021) Cost-Effectiveness Analysis: Lymph Node Transfer vs Lymphovenous Bypass for Breast Cancer-Related Lymphedema. Journal of the American College of Surgeons |
| Sun X, Zhang L, Cao Y, et al. (2020) Anti-neuraminidase Activity of Chemical Constituents of Balanophora Involucrata. Biomedical Chromatography : Bmc. e4949 |